Clinical trial
Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study
NCT02355990 is registered in ClinicalTrials.gov with Sanoculis Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study
- Lead sponsor
- Sanoculis Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2015
- Completion date
- December 15, 2020
- Enrollment
- 96 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pigmentary glaucoma, primary open angle glaucoma, pseudoexfoliative glaucoma